Li Yang

机构：Shenyang Pharmaceutical University, Zhengzhou University, Henan Academy of Sciences, Henan Cancer Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-9961-1391

发表论文 32 篇 · 总被引 1220 次 · h-index 16

代表论文

• Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment (2019 · Journal of Hematology & Oncology · 被引 217)
• Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer (2019 · Cancer Research · 被引 157)
• Serum biomarker panels for the diagnosis of gastric cancer (2019 · Cancer Medicine · 被引 149)
• Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients (2020 · Journal of Hematology & Oncology · 被引 75)
• TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas (2021 · Journal of Experimental & Clinical Cancer Research · 被引 60)
• Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer (2019 · Journal of Translational Medicine · 被引 43)